GEN Exclusives

More »

GEN News Highlights

More »
Sep 19, 2006

Luminex and Exiqon to Work Together on microRNA Products

  • Luminex® and Exiqon signed an agreement to co-develop and commercialize microRNA products. Exiqon will develop and manufacture microRNA products on behalf of the Luminex Bioscience Group, based on Luminex’ xMAP® technology and Exiqon’s Locked Nucleic Acid (LNA™) technology.

    LNAs are a class of nucleotide analogue that binds strongly to RNA and DNA targets. By including LNAs in detection probes, it is possible to design specific high-affinity detection assays for small RNA targets like miRNAs, which otherwise would not be possible using standard DNA-based detection probes.



Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

Be sure to take the GEN Poll

Using Pet Dogs with Cancer in Preclinical Trials

Do you agree that pet dogs with cancer should be used in early cancer drug trials?

More »